Position in PRPO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$173
-$128,592 QoQ
Shares Held
7
-99.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 18 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PRPO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $13,737,194,071 across 44 Diagnostics & Research names. PRPO ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
10,763,066 | $5,396,170,760 | |
| 2 | DHR |
Danaher Corp /De/
|
11,348,958 | $2,161,749,507 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,356,103 | $713,906,852 | |
| 4 | A |
Agilent Technologies, Inc.
|
5,185,738 | $688,821,571 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
465,226 | $594,330,857 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
2,707,252 | $523,095,221 | |
| 7 | DGX |
Quest Diagnostics Inc
|
2,460,497 | $521,502,333 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,609,447 | $450,645,160 |
All Filings in PRPO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $173 | 7 | Shares | Defined | 2026-08-13 | |
| 2022-03-31 | $128,765 | 95,382 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $261,213 | 165,325 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $467,375 | 165,736 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $105,847 | 29,159 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $38,999 | 16,883 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $24,500 | 10,000 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $35,500 | 25,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $17,495 | 24,993 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||